What is the intrinsic value of WGS?
As of 2025-09-08, the Intrinsic Value of GeneDx Holdings Corp (WGS) is
0.24 USD. This WGS valuation is based on the model Peter Lynch Fair Value.
With the current market price of 132.54 USD, the upside of GeneDx Holdings Corp is
-99.82%.
Is WGS undervalued or overvalued?
Based on its market price of 132.54 USD and our intrinsic valuation, GeneDx Holdings Corp (WGS) is overvalued by 99.82%.
WGS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(98.71) - (26.00) |
(40.22) |
-130.3% |
| DCF (Growth 10y) |
(25.44) - (87.59) |
(37.71) |
-128.5% |
| DCF (EBITDA 5y) |
(9.99) - (11.96) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(11.42) - (12.80) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.24 - 0.24 |
0.24 |
-99.82% |
| P/E |
0.76 - 2.67 |
1.44 |
-98.9% |
| EV/EBITDA |
8.14 - 15.32 |
12.16 |
-90.8% |
| EPV |
(68.47) - (95.50) |
(81.98) |
-161.9% |
| DDM - Stable |
0.59 - 3.12 |
1.85 |
-98.6% |
| DDM - Multi |
(17.54) - (72.93) |
(28.33) |
-121.4% |
WGS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
3,807.87 |
| Beta |
1.13 |
| Outstanding shares (mil) |
28.73 |
| Enterprise Value (mil) |
3,785.44 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.63% |
| Cost of Debt |
11.96% |
| WACC |
7.71% |